{
    "code": "02020094",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02020094",
    "time": "2015-08-23 10:25:22",
    "許可證字號": "衛署藥輸字第020094號",
    "註銷狀態": "已註銷",
    "註銷日期": "102\/10\/08",
    "註銷理由": "許可證未申請展延",
    "有效日期": "98\/07\/26",
    "發證日期": "82\/09\/15",
    "許可證種類": "製　劑",
    "舊證字號": "02004497",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202009401",
    "中文品名": "施寧錠１．５公絲",
    "英文品名": "SERENACE TABLETS 1.5MG",
    "適應症": "噪病、精神病狀態、噁心、嘔吐、攻擊性與破壞性之行為障礙、舞蹈病。",
    "劑型": "110錠劑",
    "包裝": "瓶裝 盒裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "HALOPERIDOL",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1504401100  輝瑞大藥廠股份有限公司",
    "申請商地址": "新北市淡水區中正東路二段１７７號",
    "主製造廠": {
        "製造廠名稱": "F020013000  MERISANT MANUFACTURING AUSTRALIA PTY LTD.",
        "製造廠廠址": "59, LISBON STREET, FAIRFIELD, NEW SOUTH WALES, 2165,AUSTRALIA",
        "製造廠公司地址": "20 CLARKESTREET CROWS NEST N.S.W. 2065 AUSTRALIA",
        "製造廠國別": "AUSTRALIA",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2816100300",
            "成分名稱": "HALOPERIDOL",
            "含量描述": "",
            "含量": "1.5000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "白色",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "圓扁形",
        "標記一": "SEARLE",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "圖片",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020094&Seq=424&Type=10"
        }
    ]
}